Cargando…

Disrupted tubular parathyroid hormone/parathyroid hormone receptor signaling and damaged tubular cell viability possibly trigger postsurgical kidney injury in patients with advanced hyperparathyroidism

BACKGROUND: Parathyroidectomy (PTX) that alleviates clinical manifestations of advanced hyperparathyroidism, including hypercalcemia and hypophosphatemia, is considered the best protection from calcium overload in the kidney. However, little is known about the relationship between postsurgical robus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Tetsuhiko, Kikkawa, Yamato, Yamamoto, Suguru, Tanaka, Yusuke, Kazama, Junichiro J, Tominaga, Yoshihiro, Ichimori, Toshihiro, Okada, Manabu, Hiramitsu, Takahisa, Fukagawa, Masafumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	CKD-Mbd
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768296/ https://www.ncbi.nlm.nih.gov/pubmed/31583093 http://dx.doi.org/10.1093/ckj/sfy136

Ejemplares similares

Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease
por: Ureña-Torres, Pablo A, et al.
Publicado: (2018)

Factors associated with parathyroid hormone control in haemodialysis patients with secondary hyperparathyroidism treated with cinacalcet in real-world clinical practice: Mimosa study
por: Rottembourg, Jacques, et al.
Publicado: (2019)

Vitamin D, bone alkaline phosphatase and parathyroid hormone in healthy subjects and haemodialysed patients from West Africa: impact of reference ranges and parathyroid hormone generation assays on the KDIGO guidelines
por: Cavalier, Etienne, et al.
Publicado: (2018)

Multimodal treatment of calcific uraemic arteriolopathy (calciphylaxis): a case series
por: Russo, Domenico, et al.
Publicado: (2016)

Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients
por: Cianciolo, Giuseppe, et al.
Publicado: (2016)

The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials
por: Caluwé, Rogier, et al.
Publicado: (2016)

Is progression of coronary artery calcification influenced by modality of renal replacement therapy? A systematic review
por: Jansz, Thijs T, et al.
Publicado: (2018)

Calciphylaxis in a dialysis patient successfully treated with high-dose vitamin K supplementation
por: Christiadi, Daniel, et al.
Publicado: (2018)

Multi-intervention management of calcific uremic arteriolopathy in 24 patients
por: Harris, Claire, et al.
Publicado: (2018)

Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients
por: Fouque, Denis, et al.
Publicado: (2018)

Is chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype?
por: Cianciolo, Giuseppe, et al.
Publicado: (2017)

Soluble klotho may be a marker of phosphate reabsorption
por: Tan, Sven-Jean, et al.
Publicado: (2017)

Gastrointestinal complications induced by sevelamer crystals
por: Yuste, Claudia, et al.
Publicado: (2017)

Placebo-controlled, randomized clinical trial of high-dose cholecalciferol in renal dialysis patients: effect on muscle strength and quality of life
por: Singer, Richard, et al.
Publicado: (2018)

Are oxyphil cells responsible for the ineffectiveness of cinacalcet hydrochloride in haemodialysis patients?
por: Rottembourg, Jacques, et al.
Publicado: (2018)

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3
por: Bouma-de Krijger, Annet, et al.
Publicado: (2019)

Small steps towards the potential of ‘preventive’ treatment of early phosphate loading in chronic kidney disease patients
por: Bover, Jordi, et al.
Publicado: (2019)

Intraoperative intact parathyroid hormone monitoring and frozen section diagnosis are essential for successful parathyroidectomy in secondary hyperparathyroidism
por: Hiramitsu, Takahisa, et al.
Publicado: (2022)

Intact parathyroid hormone levels localize causative glands in persistent or recurrent renal hyperparathyroidism: A retrospective cohort study
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

Pre-operative Localisation of the Parathyroid Glands in Secondary Hyperparathyroidism: A Retrospective Cohort Study
por: Hiramitsu, Takahisa, et al.
Publicado: (2019)

Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia
por: Okada, Manabu, et al.
Publicado: (2022)

A Retrospective Study of the Impact of Intraoperative Intact Parathyroid Hormone Monitoring During Total Parathyroidectomy for Secondary Hyperparathyroidism: STARD Study
por: Hiramitsu, Takahisa, et al.
Publicado: (2015)

Maximal parathyroid gland diameter as a predictive factor for autograft-dependent recurrent secondary hyperparathyroidism after total parathyroidectomy
por: Hiramitsu, Takahisa, et al.
Publicado: (2023)

Intact parathyroid hormone and whole parathyroid hormone assay results disagree in hemodialysis patients under cinacalcet hydrochloride therapy
por: Koda, Ryo, et al.
Publicado: (2014)

Radioimmunoassay of Parathyroid Hormone in Primary Hyperparathyroidism
por: Buckle, R. M.
Publicado: (1968)

Predictors of Bone Mineral Density Improvement after Parathyroidectomy for Secondary Hyperparathyroidism: A Retrospective Single-Center Analysis
por: Okada, Manabu, et al.
Publicado: (2021)

Parathyroid hormone-producing cells exist in adipose tissues surrounding the parathyroid glands in hemodialysis patients with secondary hyperparathyroidism
por: Kakuta, Takatoshi, et al.
Publicado: (2020)

The value of intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism and varying baseline parathyroid hormone levels
por: Hargitai, Lindsay, et al.
Publicado: (2022)

Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism
por: Fang, Li, et al.
Publicado: (2015)

Parathyroid Hormone on Osteoprotegerin Levels in Patients with Primary Hyperparathyroidism
por: Okudan, Berna, et al.
Publicado: (2022)

Evaluation of Postural Parathyroid Hormone Change in Patients with Primary Hyperparathyroidism
por: Aydin, Cevdet, et al.
Publicado: (2014)

Clinical usefulness of intraoperative parathyroid hormone monitoring for primary hyperparathyroidism
por: Paek, Se Hyun, et al.
Publicado: (2018)

The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation
por: Tabibzadeh, Nahid, et al.
Publicado: (2020)

Use of intraoperative parathyroid hormone measurements during parathyroidectomy to predict postoperative parathyroid hormone levels in patients with renal hyperparathyroidism: meta-analysis
por: van Beek, Dirk-Jan, et al.
Publicado: (2022)

Minimally invasive parathyroidectomy with or without intraoperative parathyroid hormone for primary hyperparathyroidism
por: Kim, Hyun Gu, et al.
Publicado: (2015)

Intraoperative Parathyroid Hormone Monitoring in the Surgical Management of Sporadic Primary Hyperparathyroidism
por: Khan, Zahra F., et al.
Publicado: (2019)

The Importance of Correlation between Aldosterone and Parathyroid Hormone in Patients with Primary Hyperparathyroidism
por: Milicic Stanic, Branka, et al.
Publicado: (2022)

Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation
por: Kimura, Shigemi, et al.
Publicado: (2014)

Persistent hyperparathyroidism after preemptive kidney transplantation
por: Okada, Manabu, et al.
Publicado: (2023)

Treatment for secondary hyperparathyroidism focusing on parathyroidectomy
por: Hiramitsu, Takahisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_251gfl5to1tnr8issuodbu018u